RonnieJamesKirschlingMD

Oncology • Wisconsin Rapids, WI

Physician

Join to view full profile

Dr. Kirschling is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kirschling's full profile

Already have an account?

Office
410 Dewey Street
Wisconsin Rapids, WI 54494
Phone+1 715-421-7442
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1982 - 1985
San Antonio Uniformed Services Health Education ConsortiumInternship, Transitional Year, 1979 - 1980
Medical College of WisconsinClass of 1979

Certifications & Licensure

WI State Medical License 1997 - 2025
MN State Medical License 1992 - 2024
TX State Medical License 1980 - 1999
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
Completed
Phase 1, Phase 2
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Active, not recruiting
Phase 2
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Jan 24
Active, not recruiting
Phase 2
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Feb 20
Active, not recruiting
Phase 3
Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. Start of enrollment: 2014 Sep 11
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

Vorinostat (V) and bortezomib (B) as third-line treatment in patients with advanced non-small cell lung cancer (NSCLC): A Wisconsin Oncology Network Phase II Study.
Jones MW, Zhang C, Oettel KR, Blank JH, Robinson EG, Ahuja HG, Kirschling RJ, Johnson PH, Huie MS, Kolesar J, Wims MB, Hernan H, Campbell TC, Traynor AM, Hoang T> ;J. Clin. Oncol.. 2011-05-20
2 citations
Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer.
James N. Ingle, Carl G. Kardinal, Vera J. Suman, Michael H. Veeder, Paul L. Schaefer, Ronnie J. Kirschling, James A. Mailliard> ;Breast Cancer Research and Treatment. 1997 May 1
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group.
Kirschling, R. J., Grill, J. P., Marks, R. S., Kugler, J. W., Gerstner, J. B., Kuross, S. A., Michalak, J. C., Windschitl, H. E., Krewer, K. D., Jett, J. R.> ;Am J Clin Oncol. 1999 Oct
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Pitot, H. C., Wender, D. B., O'Connell, M. J., Schroeder, G., Goldberg, R. M., Rubin, J., Mailliard, J. A., Knost, J. A., Ghosh, C., Kirschling, R. J., Levitt, R., Win...> ;J Clin Oncol. 1997 Aug
A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: a study of the N...
Jett, J. R., Kirschling, R. J., Jung, S. H., Marks, R. S.> ;Semin Oncol. 1995 Jun
High-resolution ultrasonographic and pathologic abnormalities of germ cell tumors in patients with clinically normal testes.
Kirschling, R. J., Kvols, L. K., Charboneau, J. W., Grantham, J. G., Zincke, H.> ;Mayo Clin Proc. 1983 Oct
Testicular neoplasms: 29 tumors studied by high-resolution US.
Grantham, J. G., Charboneau, J. W., James, E. M., Kirschling, R. J., Kvols, L. K., Segura, J. W., Wold, L. E.> ;Radiology. 1985 Dec
Join now to see all

Hospital Affiliations

Aspirus Riverview Hospital and Clinics, Inc.Wisconsin Rapids, Wisconsin
Aspirus Ironwood HospitalIronwood, Michigan